Page last updated: 2024-10-31

nadifloxacin and Skin Diseases, Infectious

nadifloxacin has been researched along with Skin Diseases, Infectious in 1 studies

nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source

Skin Diseases, Infectious: Skin diseases caused by bacteria, fungi, parasites, or viruses.

Research Excerpts

ExcerptRelevanceReference
"Nadifloxacin (NDFX) is a fluoroquinolone antibiotic developed by Otsuka Pharmaceutical Co."1.33[Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections]. ( Hasegawa, M; Kobayashi, I; Matsuzaki, K; Omika, K; Sato, Y, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuzaki, K1
Omika, K1
Hasegawa, M1
Sato, Y1
Kobayashi, I1

Other Studies

1 other study available for nadifloxacin and Skin Diseases, Infectious

ArticleYear
[Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:4

    Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Methicillin Resistance; Propionibacterium; Quinoliz

2006